Selective adenosine agonists and myocardial perfusion imaging.
Article Details
- CitationCopy to clipboard
Zoghbi GJ, Iskandrian AE
Selective adenosine agonists and myocardial perfusion imaging.
J Nucl Cardiol. 2012 Feb;19(1):126-41. doi: 10.1007/s12350-011-9474-9.
- PubMed ID
- 22130964 [ View in PubMed]
- Abstract
Selective adenosine receptor agonists have several advantages for use as stress agents in conjunction with myocardial perfusion imaging compared to the non selective agents such as adenosine and dipyridamole. This review will summarize the pre-clinical and clinical data on the selective adenosine agonist stress agents regadenoson (Lexiscan((R))), binodenoson (CorVue) and apadenoson (Stedivaze) that have been studied so far with focus on regadenoson that has the most clinical data published so far. The article will review the adenosine receptor types and properties. It will also review the various attributes of the selective adenosine agonists including their pharmacology, pharmacokinetics and pharmacodynamics, their coronary vasodilatory and hemodynamic effects, their safety and side effects, their interactions with other drugs and their use with myocardial perfusion imaging. The landmark trials of the selective adenosine agonists will be reviewed as well as their use in special patient populations undergoing stress myocardial perfusion imaging.
DrugBank Data that Cites this Article
- Drugs
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Regadenoson Adenosine receptor A2a Protein Humans YesAgonistDetails